CUTR - Rasio utang marang kapitalisasi buku Cutera Inc.

Logo korporat perusahaan Cutera, Inc. (CUTR)

Regular sales of laser consumables provide a steady profit stream for Cutera, Inc. (CUTR). The company's total debt-to-equity ratio reflects borrowing dynamics, where the 0.00 metric serves as the target level. Strong confidence among medical professionals in Face + Body systems strengthens the brand's position, although demand for equipment remains cyclical and dependent on consumer spending on cosmetology.

Cutera, Inc. - Utang-utang marang kapitalisasi buku CUTR (periode 04.07.2022 - 22.03.2025)
Barang unggulan Cutera Inc

Competition in the aesthetic medicine sector and the limited pricing power of Cutera, Inc. (CUTR) necessitate strict control over financial stability. This indicator measures the ratio of total liabilities to equity on the balance sheet, determining the business's degree of dependence on borrowed funds. The metric allows for an assessment of default risk and the capital cushion in the event of falling sales. It is critical for investors to monitor the balance between debt load and growth potential. This chart of the debt-to-equity structure objectifies this data based on session closing prices.

Pesaing Cutera, Inc.

DXCM: Utang-utang marang kapitalisasi buku|penumbrainc.com - Utang-utang marang nilai buku|Rasio utang marang kapitalisasi buku Novanta (NOVT)|HAE - Rasio utang marang aset resik|INSP: Utang-utang marang kapitalisasi buku|PRCT (Procept) - Utang-utang marang kapitalisasi buku|Rasio utang marang kapitalisasi buku CONMED Corporation CNMD|Rasio utang-utang marang kapitalisasi buku pulsebiosciences.com|InMode - Utang-utang marang kapitalisasi buku|Utang-utang marang nilai buku Picard Medical Corp PMI|Utang marang nilai buku SRDX (Surmodics Corp)|SENS - Utang-utang marang kapitalisasi buku|Utang marang nilai buku NeuroPace, Inc. NPCE|TCMD - Utang marang modal buku|SANUWAVE - Utang-utang marang kapitalisasi buku|Outset Medical Inc (OM) - Utang-utang marang aset resik|Utang-utang marang kapitalisasi buku ELMD|Utang marang nilai buku LENSAR Inc (LNSR)|AVITA Medical, Inc. (RCEL) - Utang marang nilai buku|Rasio utang marang aset resik PROF (profoundmedical.com)|Baird Medical - Rasio utang marang kapitalisasi buku|Utang marang nilai buku EDAP TMS SA EDAP|APYX (Bovie Medical) - Utang-utang marang kapitalisasi buku|ICCM - Utang-utang marang nilai buku|Utang-utang marang kapitalisasi buku pulmonx.com|TELA Bio (TELA) - Rasio utang marang nilai buku|CTSO: Utang-utang marang kapitalisasi buku|Utang-utang marang aset resik Sensus Healthcare Inc|Utang-utang marang kapitalisasi buku ZYXI (Zynex Inc)|Utang marang nilai buku electrocore.com (ECOR)|Utang-utang marang kapitalisasi buku RBOT (Vicarious Surgical)|Inspira Technologies Oxy B.H.N. Ltd. - Utang-utang marang kapitalisasi buku|ICU - Rasio utang marang kapitalisasi buku|IRIDEX Corporation (IRIX) - Rasio utang marang kapitalisasi buku|Utang marang nilai buku ibs.inc INBS|Beyond Air (XAIR) - Rasio utang marang aset resik|Utang-utang marang kapitalisasi buku PFSA (Profusa Inc)|Utang-utang marang nilai buku SSKN|GCTK: Rasio utang marang kapitalisasi buku|Utang marang aset resik NanoVibronix Inc. NAOV|Utang marang nilai buku VERO (Venus Concept Corp)|Utang-utang marang kapitalisasi buku Nuwellis Corp NUWE|Utang-utang marang kapitalisasi buku AEMD (Aethlon Medical)|ASXC: Utang-utang marang aset resik|Rasio utang marang kapitalisasi buku Avinger (AVGR)|BSGM (biosig.com) - Rasio utang-utang marang kapitalisasi buku|Rasio utang marang kapitalisasi buku KNW|Utang marang nilai buku Inari Medical Corp|Nevro Corp. - Utang-utang marang kapitalisasi buku|Utang-utang marang nilai buku RSLS (reshapelifesciences.com)|SILK - Rasio utang marang kapitalisasi buku